Literature DB >> 6094444

Antibiotic prophylaxis in hysterectomy--cefotaxime compared to ampicillin-tinidazole.

P J McDonald, T Sanders, G Higgins, L Finlay-Jones, M Hakendorf, J Turnidge, W Jones.   

Abstract

The role of prophylactic cefotaxime and a combination of ampicillin and tinidazole was assessed in 201 patients undergoing hysterectomy. One hundred and twenty-five patients were evaluated in the abdominal hysterectomy group and 46 patients completed the protocol after vaginal hysterectomy. Patients were allocated randomly to receive either (1) no prophylactic antibiotic, (2) cefotaxime peroperatively for 24 h or (3) ampicillin/tinidazole peroperatively for 24 h. Both cefotaxime and ampicillin/tinidazole reduced the septic complication rate in abdominal and vaginal hysterectomy. Efficacy was most evident in reducing early urinary infections after abdominal hysterectomy (0.001 less than P less than 0.01). Cefotaxime and ampicillin/tinidazole were equally effective and no significant side-effects were demonstrated. Cefotaxime is recommended as a safe and effective agent for hysterectomy prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094444     DOI: 10.1093/jac/14.suppl_b.223

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Antibiotic prophylaxis for elective hysterectomy.

Authors:  Reuben Olugbenga Ayeleke; Selma Mourad; Jane Marjoribanks; Karim A Calis; Vanessa Jordan
Journal:  Cochrane Database Syst Rev       Date:  2017-06-18

Review 2.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

3.  Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.

Authors:  H H Bräutigam; H Knothe; R Rangoonwala
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Optimal duration of cefotaxime prophylaxis in abdominal and vaginal hysterectomy.

Authors:  P J McDonald; R Sanders; J Turnidge; P Hakendorf; P Jolley; H McDonald; O Petrucco
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.